MISSION WEALTH MANAGEMENT, LP
Position in CPRX — Catalyst Pharmaceuticals, Inc.
CIK 1645382
Santa Barbara, CA
Position in CPRX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$352,078
+$352,078 QoQ
Shares Held
11,202
+0.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#44
of 102 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MISSION WEALTH MANAGEMENT, LP holds $7,414,287 across 8 Biotechnology names. CPRX ranks #6 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,170 | $4,058,284 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,357 | $846,143 | |
| 3 | EXEL |
Exelixis, Inc.
|
12,301 | $669,297 | |
| 4 | INCY |
Incyte Corp
|
4,772 | $540,953 | |
| 5 | GPCR |
Structure Therapeutics Inc.
|
7,583 | $406,979 | |
| 6 | CPRX |
Catalyst Pharmaceuticals, Inc.
This page
|
11,202 | $352,078 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
5,739 | $328,385 | |
| 8 | RPRX |
Royalty Pharma plc
|
3,784 | $212,168 |
All Filings in CPRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $352,078 | 11,202 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | — | 11,121 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | — | 11,118 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | — | 10,818 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | — | 10,620 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | — | 10,110 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | — | 10,100 | Shares | Sole | 2025-02-06 | |
| No filing history on record for this holder in this stock. | ||||||